Vanishing contrast enhancement in malignant glioma after corticosteroid treatment

Author： Zaki H. S.   Jenkinson M. D.   Du Plessis D. G.   Smith T.   Rainov N. G.  

Publisher： Springer Publishing Company

ISSN： 0001-6268

Source： Acta Neurochirurgica, Vol.146, Iss.8, 2004-07, pp. : 841-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Convection-enhanced delivery in the treatment of malignant glioma

By Lopez Kim A.   Waziri Allen E.   Canoll Peter D.   Bruce Jeffrey N.  

Neurological Research, Vol. 28, Iss. 5, 2006-07 ,pp. : 542-548

Maney Publishing

Access to resources Recommend Favorite

Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines

By Selznick Lee  

Neurosurgical Review, Vol. 31, Iss. 2, 2008-04 ,pp. : 141-155

Springer Publishing Company

Access to resources Recommend Favorite

Development of malignant glioma 15 months after anterior temporal lobectomy in a patient with temporal lobe epilepsy

By Morino M.   Ichinose T.   Terakawa Y.   Haba T.   Wakasa K.   Ohata K.   Hara M.  

Acta Neurochirurgica, Vol. 146, Iss. 1, 2004-01 ,pp. : 59-63

Springer Publishing Company

Access to resources Recommend Favorite

Postoperative communicating hydrocephalus in patients with supratentorial malignant glioma

By Inamasu J.   Nakamura Y.   Saito R.   Kuroshima Y.   Mayanagi K.   Orii M.   Ichikizaki K.  

Clinical Neurology and Neurosurgery, Vol. 106, Iss. 1, 2003-12 ,pp. : 9-15

Elsevier

Access to resources Recommend Favorite

Immunotherapy for malignant glioma: current approaches and future directions

By Sikorski Christian W.   Lesniak Maciej S.  

Neurological Research, Vol. 27, Iss. 7, 2005-10 ,pp. : 703-716

Maney Publishing

Access to resources Recommend Favorite